RAD21 antibody (C-Term)
Quick Overview for RAD21 antibody (C-Term) (ABIN2452087)
Target
See all RAD21 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purification
- Affinity purified with immunogen peptide from rabbit serum of immunized rabbit
-
Sterility
- Sterile filtered
-
Immunogen
- Human Rad21 C-terminal peptide, C-ATPGPRFHII
-
-
-
-
Application Notes
-
1) Western blotting: 1/2,000 dilution
2) Immunofluorescence staining: 1/100~1/500 dilution -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS (x1), 50 % glycerol. Azide and carrier free.
-
Preservative
- Azide free
-
Storage
- -20 °C
-
Storage Comment
- Upon arrival centrifuge briefly and store at -20 C.
-
-
-
: "Derivation of a dysplasia index for epidermal neoplasia." in: Dermatology (Basel, Switzerland), Vol. 185, Issue 3, pp. 190-5, (1992) (PubMed).
-
: "Derivation of a dysplasia index for epidermal neoplasia." in: Dermatology (Basel, Switzerland), Vol. 185, Issue 3, pp. 190-5, (1992) (PubMed).
-
- RAD21 (RAD21 Homolog (RAD21))
-
Alternative Name
- Rad21
-
Background
- Rad21 (631 aa, 71 kDa) 2) is a cleavable component of cohesin complex, involved in chromosome cohesion during cell cycle, in DNA repair, and in apoptosis. The cohesin complex is required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At metaphase-anaphase transition, this protein is cleaved by separase/ESPL1 and dissociates from chromatin, allowing sister chromatids to segregate.
-
UniProt
- O60216
-
Pathways
- Positive Regulation of Endopeptidase Activity
Target
-